Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients
Conditions:   Non-Hodgkin's Lymphoma (NHL);   Peripheral T Cell Lymphoma (PTCL) Intervention:   Biological: Ex-vivo expanded allogeneic γδT cells Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Beijing GD Initiative Cell Therapy Technology Co.,Ltd.;   Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2021 Category: Research Source Type: clinical trials

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Conditions:   Acute Myeloid Leukemia;   Non-hodgkin's Lymphoma;   Multiple Myeloma Intervention:   Drug: CD70 CAR T-cells Sponsors:   Zhejiang University;   Yake Biotechnology Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2020 Category: Research Source Type: clinical trials